Skip to main content
Swing Capital

Krsnaa Diagnostics Ltd

NSE: KRSNAA BSE: 543328Healthcare

Krsnaa Diagnostics Ltd provides a range of technology-enabled diagnostic services such as imaging, clinical laboratory, and teleradiology services to hospitals, medical colleges, and community health centers across India with an extensive network across non-metro and lower-tier cities and towns.[1]

₹564
52W: ₹502 — ₹894
PE 22.8 · Book ₹287 · +97% vs book
Market Cap₹1,828 Cr
Stock P/E22.8Price to Earnings
ROCE12.5%Return on Capital
ROE9.29%Return on Equity
Div. Yield0.48%Face Value ₹5

Weaknesses

  • −Promoter holding is low: 27.1%
  • −Company has a low return on equity of 8.57% over last 3 years.
  • −Dividend payout has been low at 12.7% of profits over last 3 years
  • −Company has high debtors of 152 days.

Shareholding Pattern

Promoters27.11%
FIIs3.91%
DIIs13.89%
Public55.09%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters27.17%27.17%27.24%▲0.127.24%27.11%▼0.127.11%27.11%27.11%
FIIs3.33%3.63%▲0.34.04%▲0.43.55%▼0.53.4%▼0.13.66%▲0.34.17%▲0.53.91%▼0.3
DIIs15.26%15.86%▲0.614.46%▼1.414.26%▼0.214.24%▼0.014.96%▲0.713.85%▼1.113.89%▲0.0
Public54.23%53.34%▼0.954.27%▲0.954.94%▲0.755.25%▲0.354.27%▼1.054.86%▲0.655.09%▲0.2

Financial Statements

MetricSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales147152159163179165175176183159
Expenses116113116120126117121126125112
Operating Profit31384343524853505848
OPM %21%25%27%26%29%29%31%29%32%30%
Net Profit11141818222221202316
EPS ₹3.64.215.75.636.86.696.536.037.165.08

AI Insights

Revenue Trend

TTM revenue at ₹693Cr, up 1.6% YoY. OPM at 30%.

Debt Position

Borrowings at ₹284Cr. Debt-to-equity ratio: 0.31x. Healthy balance sheet.

Capex Cycle

CWIP at ₹30Cr (4% of fixed assets). Moderate ongoing capital expenditure.

Institutional Flow

DIIs: 13.89% (-5.88pp change). FIIs: 3.91% (-1.78pp change). Promoters hold 27.11%.

Margin & Efficiency

ROCE improving from 0% (Mar 2016) to 13% (Mar 2025). Working capital days: 28.

Valuation

PE 22.8x with 12.5% ROCE. Price is 97% above book value of ₹287. Dividend yield: 0.48%.

Recent Announcements